Cabozantinib in Advanced Neuroendocrine Tumors
Year: 2025
Type: letter
Source: New England Journal of Medicine
DOI: 10.1056/nejmc2503524
Authors: Jennifer A Chan, Susan Geyer, Jeffrey A Meyerhardt
Institutions: Dana-Farber Cancer Institute, Mayo Clinic
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4410141779
